Home > Result Summaries: Compounds > fosamprenavir > Result Summary for APV10007

Result Summary for APV10007

Result Summary

Protocol ID:	APV10007
Clinical Study ID:	APV10007
Official Title:	A Phase I, Single-dose, Open-label, Randomized, Three-way, Balanced, Crossover Study to Assess the Effect of MAALOX TC and ZANTAC on Plasma Amprenavir Pharmacokinetics Following Administration of a 1400mg Single Dose of GW433908
Phase:	Phase 1
Study Indications or Diseases:	Infection, Human Immunodeficiency Virus
Generic Name:	fosamprenavir
Trade/Product Name:	lexiva;lexiva
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	Ford SL, Wire MB, Lou Y, Baker K, Stein DS. Effect of antacids and ranitidine on the single-dose pharmacokinetics of fosamprenavir. Antimicrob Agents Chemother. 2005;49: 467-9.